UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000018266 |
|---|---|
| Receipt number | R000021142 |
| Scientific Title | A randomized controlled trial comparing conventional ESD versus ESD with dental floss-clip traction for gastric epithelial neoplasia (CONNECT-G trial) |
| Date of disclosure of the study information | 2015/07/10 |
| Last modified on | 2018/01/10 12:19:08 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A randomized controlled trial comparing conventional ESD versus ESD with dental floss-clip traction for gastric epithelial neoplasia (CONNECT-G trial)
Acronym
A randomized controlled trial comparing conventional ESD versus ESD with dental floss-clip traction for gastric epithelial neoplasia (CONNECT-G trial)
Scientific Title
A randomized controlled trial comparing conventional ESD versus ESD with dental floss-clip traction for gastric epithelial neoplasia (CONNECT-G trial)
Scientific Title:Acronym
A randomized controlled trial comparing conventional ESD versus ESD with dental floss-clip traction for gastric epithelial neoplasia (CONNECT-G trial)
Region
| Japan |
Condition
Condition
Gastric epithelial neoplasia
Classification by specialty
| Gastroenterology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To comfirm the superiority of dental floss-clip ESD to conventional ESD in terms of procedure time for patients with gastric epithelial neoplasia.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Phase III
Assessment
Primary outcomes
ESD procedure time
Key secondary outcomes
ESD procedure time according to the proficiency of the operator (trainee or expert), the location of the lesion, the presence of ulcer findings and tumor size; self completion rate of ESD among beginners; procedure time of hemostasis; times of hemostasis; damage of specimen caused by dental floss-clip traction; en bloc resection rate; complete en bloc resection rate; serious adverse events
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Active
Stratification
YES
Dynamic allocation
YES
Institution consideration
Institution is considered as adjustment factor in dynamic allocation.
Blocking
NO
Concealment
Central registration
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Device,equipment |
Interventions/Control_1
A: Conventional ESD group
Interventions/Control_2
B: Dental floss-clip ESD group
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Histologically proven gastric adenoma or cancer, which is within the absolute or expanded indication of ESD according to Japanese gastric cancer treatment guideline 2014.
2) ESD for one lesion.
3) No gastrectomy and no reconstructive surgery of gastric tube for esophageal cancer.
4) Aged 20 years old or more.
5) ECOG performance status of 0, 1 or 2.
6) The possibility of stenosis after ESD is low. All of the following conditions must be fulfilled:
i) Predicted line of mucosal incision is not on the EG junction.
ii) Predicted line of mucosal incision is not on the pylorus.
7) Adequate organ functions and all of the following conditions within 56 days at registration must be fulfilled:
i) Hb is no less than 9.0 g/dl,
ii)Plt is no less than 100,000 /mm3.
8) Follow up for 30 days after ESD.
9) Written informed consent.
Key exclusion criteria
1) Impossible to suspend anticoagulant or antiplatelet medications except low-dose aspirin.
2) Infectious disease with systemic therapy indicated.
3) Women during pregnancy or breast-feeding.
4) Severe psychiatric disease.
5) Systemic steroids medication.
6) History of myocardial infarction within 6 months or unstable angina pectoris within 3 weeks.
7) Severe respiratory disease requiring continuous oxygen therapy.
8) Uncontrollable hypertension.
9) Uncontrollable diabetes millutus or administration of insulin.
Target sample size
640
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kohei Takizawa |
Organization
Shizuoka Cancer Center
Division name
Division of Endoscopy
Zip code
Address
1007 Shimonagakubo, Nagaizumi-cho, Sunto-Gun, Shizuoka 411-8777, JAPAN
TEL
055-989-5222
k.takizawa@scchr.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Masao Yoshida |
Organization
Shizuoka Cancer Center
Division name
Division of Endoscopy
Zip code
Address
1007 Shimonagakubo, Nagaizumi-cho, Sunto-Gun, Shizuoka 411-8777, JAPAN
TEL
055-989-5222
Homepage URL
ma.yoshida@scchr.jp
Sponsor or person
Institute
Shizuoka Cancer Center
Institute
Department
Personal name
Funding Source
Organization
Shizuoka Cancer Center
Organization
Division
Category of Funding Organization
Local Government
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
大阪府立病院機構大阪府立成人病センター（大阪府）
岡山大学医学部（岡山県）
がん研究会有明病院（東京都）
北里大学医学部（神奈川県）
埼玉医科大学国際医療センター（埼玉県）
国立病院機構四国がんセンター（愛媛県）
静岡県立静岡がんセンター（静岡県）
仙台オープン病院（宮城県）
国立がん研究センター東病院（千葉県）
国立がん研究センター中央病院（東京都）
東京大学医学部（東京都）
斗南病院（北海道）
福島県立医科大学（福島県）
由利組合総合病院（秋田県）
横浜市立大学附属市民総合医療センター（神奈川県）
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 07 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 07 | Month | 02 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 07 | Month | 21 | Day |
Last follow-up date
| 2016 | Year | 09 | Month | 04 | Day |
Date of closure to data entry
| 2016 | Year | 09 | Month | 11 | Day |
Date trial data considered complete
Date analysis concluded
| 2016 | Year | 09 | Month | 30 | Day |
Other
Other related information
Management information
Registered date
| 2015 | Year | 07 | Month | 10 | Day |
Last modified on
| 2018 | Year | 01 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021142
